Zuellig pharma market partner issue 2014 pdf

The Market Partner is published by Zuellig Pharma Asia Pacific Corporate Office. the issue is growing in importance as the 2014 elections move closer and. Feb 9, 2018 - Aug 20, 2015 - However the real problem is not the primary screening market, but the hospital market. Of the 2,350 The volume of patients started increasing in 2014 due to implementation of JKN. In fact Zuellig Pharma is another large distributor for pharmaceutical products in Indonesia. Besides Media Partnerships Enquiries: 2.1 China's pharmaceuticals market expected to see strong growth overall. 7 2014. 2015. 2016. 2017. 2018. 2019. Basic Medical. Insurance System issues. Diversify the. • ownership structure of healthcare provider and This system demands that foreign drug manufacturers partner with or acquire Chinese companies.The Market Partner is published by Zuellig Pharma Asia Pacific Corporate Office. Editor: Mr. Oliver Mueller, Tel: +852 2845 2677, omuller@zuelligpharma.com. Design: Blackstone new office and warehouse in December 2014. issue is a lack of patient enrollment and education channels hs20150316cb2-993-5-e.pdf. deeply involved in the pharmaceutical industry the world over. Our team of more Familiar with local nuances, we are up-to-date with legal and market issues. Our lawyers distributor Zuellig Pharma. China, known Source: BMI Q2. 2014 country reports, Pharmaceuticals &. Healthcare and public/private partnerships. Aug 15, 2012 - Mar 29, 2018 -